A B S T R A C T We have recently characterized two lymphocyte-associated membrane proteins which have been termed 225,000-dalton and 185,000-dalton macromolecular insoluble cold globulin (225-MICG and 185-MICG, respectively) to distinguish their major physicochemical properties. These proteins differ antigenically, structurally, and in their cellular distribution. T 
A B S T R A C T We have recently characterized two lymphocyte-associated membrane proteins which have been termed 225,000-dalton and 185,000-dalton macromolecular insoluble cold globulin (225-MICG and 185-MICG, respectively) to distinguish their major physicochemical properties. These proteins differ antigenically, structurally, and in their cellular distribution. T cells can be distinguished by the synthesis and presence in the plasma membrane of 225-MICG, Null cells by the appearance of 185-MICG, and B cells by the appearance of both 225-and 185-MICG. The characterization of these two proteins in the monoclonal B lymphocytes of chronic lymphocytic leukemia forms the basis of this report.
Using immunofluorescent microscopy, we found only 225-MICG on the surface of chronic lymphocytic leukemia (CLL) cells in 15 patients, whereas control B cells from 20 (1) (2) (3) (4) (5) (6) (7) . Chronic lymphocytic leukemia (CLL)' has been shown to be a monoclonal malignant disorder with properties of normal B cells, i.e., the cells bear surface immunoglobin (SIg), usually IgM, IgD, or both, of a single light and heavy chain isotype (8) (9) (10) (11) (12) (13) . The monoclonal SIg on CLL cells has been shown to have antibody activity, supporting the concept that SIg on normal B cells is the receptor responsible for antigen recognition (1, 2) . Cell surface marker characterization ofvarious malignant clones has also suggested pathways along which normal lymphocyte differentiation could progress (14, 15 Boston, Mass., as described (19, 20, 27, 28) . The cells were incubated for 4 h at 37°C in a mixture of 95% air-5% CO2 in a humidified atmosphere (29, 30 ). The radiolabeled cells were then immersed in ice water, made 0.06 M in iodoacetamide, and centrifuged at 400g for 10 min. The supernates were collected and termed "secretions." The cells were washed extensively and resuspended in 1.5 ml of isotonic buffer, pH 7.2 (29) .
Detergent lysis of radiolabeled cells and immune precipitation of cell lysates and of secretion. Desoxycholate (Fischer Scientific Co., Fairlawn, N. J.) was added to the radiolabeled cell suspension to yield a final concentration of 0.5% (vol/vol), and the mixture was made 0.12 M with respect to iodoacetamide and 1,000 U/nil with respect to Trasylol (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) added (19) . After incubation for 20 min at 4°C, the resultant cell lysate was centrifuged at 105,000 g for 30 min at 4°C; the pellet was discarded. Radiolabeled lysates and secretions in a volume of 1.6 or 3.0 ml, respectively, were immune precipitated by the direct technique using anti-225-MICG antiserum (250 ,ul), anti-185-MICG (250 ,ul), or antiserum with reactivity toward both 225-and 185-MICG, i.e., anti-225 + 185-MICG antiserum (250 ,ul), in antibody excess. Incubation of antiserum with cell lysates proceeded at 40C for 16 h. Under these conditions, MICG proteins remained soluble, enabling MICG to be immune-precipitated from whole cell lysates. The precipitates were washed and dissolved in sodium dodecyl sulfate-urea buffer (see below).
Isolation of MICG by cold precipitation. Isolated cells were lysed in isotonic buffer containing 0.5% Nonidet P-40 as previously described, with the exception that the iodoacetami4e concentration was increased to 0.12 M (19, 20, 27, 28) .
The cell lysates were centrifuged at 105,000 g for 30 min at 40C, the pellet discarded, and the supemate incubated at 40C for 24 h. The cold precipitate was solubilized in 1% (wt/vol) sodium dodecyl sulfate (SDS)-8 M urea-0.06 M iodoacetamide-Trasylol (1,000 U/ml)-0.1 M Tris buffer, pH 9.2 (SDSurea buffer) (19, 20) . Details of 225-and 185-MICG cold precipitation, preparation of anti-human MICG antisera, and SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (5%) have been previously reported (18-20, 27, 28) . Solubilized cold and immune precipitates were reduced with 0.5 M 2-mercaptoethanol for 1 h at 370C, alkylated with 0.65 M iodoacetamide, and then dialyzed (19) . Protein determination was as previously described (3) . Equal amounts of protein (20-50 ,ug) were applied to gels that were to be directly compared.
Antiserum absorption. Heat-inactivated (560C) antiserum to human 225 + 185-MICG was absorbed in 0.5 ml aliquots with 700-750 x 106 T cells, normal B cells, or CLL cells for 3 h at 40C with shaking. The mixtures were centrifuged at 1,000 g for 20 min, and the supemate was collected.
Antiserum absorbed in this fashion was stored at -700C.
Immunofluorescence. Indirect immunofluorescence was performed on viable PBL and subpopulations as previously Absence of 185,000-Dalton Globulin in Chronic Lymphocytic Leukemia detailed (19, 25, 31, 32) . Briefly, lymphocytes (2 x 106) were incubated for 1 h at 37°C in 3 ml of minimum essential medium supplemented with 20% FCS and 0.2% sodium azide to remove cytophilic antibody. The cells were washed at 370C, resuspended in 0.1 ml of medium without FCS, and incubated at 40C for 30 min with 0.1 ml of anti-human 225-, anti-human 185-, or anti-human 225 + 185-MICG antiserum (1:32). The antiserum employed was the IgG fraction (33) . The cells were washed three times and resuspended in 0.1 ml of medium, and 0.1 ml of FITC-conjugated goat anti-rabbit IgG (GARIgG) (Behring Diagnostics) (1:32) was added. Incubation was continued for 30 min at 4°C. The cells were washed three times and finally resuspended in 0.1 ml of medium. A drop ofthe cell suspension was applied to a microscope slide with the bottom of a 12 x 75-mm test tube and fixed in ethanol (95%), and a cover slip was applied in buffered glycerol (34) .
Indirect immunofluorescence specificity controls consisted of normal (Fig. 2) Fig. 2A show that 185-MICG is found on the cell surface of two of the PBL, only one of which is also SIg+ (Fig. 2B) (Fig. 3) . T cells demonstrated a 225,000 dalton protein and normal B cells both 0 a 225,000-and a 185,000-dalton protein (Fig. 3, left and middle). However, in CLL cells from all patients, * * only the 225,000-dalton protein was detected (Fig. 3,   9 right).
Further evidence for the absence of 185-MICG in CLL cells was sought using immunofluorescence. Lymphocyte subpopulations were isolated and reacted with either anti-225 + 185-MICG or anti-185-MICG . The lysates were cold precipitated and fluorescent microscopy with selective filters for FITC (A), the isolated protein (25) ,ug) reduced and subjected to 5% TRITC (B), or phase-contrast microscopy (C). SDS-PAGE; the gels were stained with 0.5% coomassie blue.
antiserum. The latter antiserum, made from the former antiserum by absorbing with T cells, reacted with labeled 185,000-dalton MICG and not with 225,000-dalton MICG. Anti-225 + 185-MICG antiserum stained the cell surface ofnormal T, B, and CLL cells in a ringed pattern (Fig. 4A-C) , whereas anti-185-MICG antiserum did not stain T cells (Fig. 4D) , although it reacted with normal B cells (Fig. 4E) . In contradistinction, anti-185-MICG antiserum did not stain CLL cells (Fig. 4F) (Fig. 6c) . Surprisingly, neither 225-nor 185-MICG was detected in the secretion from CLL cells (Fig. 6d) , whereas normal B cell secretions demonstrated the presence of (Fig. 6b) . Similar results were obtained when MICG was isolated from radiolabeled cell lysates by cold precipitation. DISCUSSION A considerable number of lymphoproliferative diseases have been recognized as monoclonal B cell disorders. Chronic lymphocytic leukemia and the majority of lymphomas in adults are B cell malignancies (11, 12, 36) . In a given patient with CLL, all the leukemic cells will have either kappa or lambda-type immunoglobin on their cell surface, whereas normal B lymphocytes consist of a mosaic of kappa-and lambdacontaining cells in a ratio of -2:1 (10) . The same CLL cell may have SIgM and SIgD, but both immunoglobulins then share a common idiotype, indicating that a single heavy chain variable region can be joined to different constant regions (37) . These studies have helped to establish the concept that certain lymphoid malignancies might represent an aberrant expansion of a single transformed cell.
We have previously shown that T cells produce 225-MICG, and N cells produce 185-MICG (19, 20) . Although both of these proteins were shown to be synthesized by and present on the cell surface of normal B cells, only 225-MICG was present in CLL B cells. The (38, 39) . In contrast to our secretory study, which was accomplished in 4 h without FCS and mitogen, these studies cultured CLL cells for 6 d and used FCS and mitogen. Under the latter conditions it is thought that lymphocytes differentiate into plasma cells (40) (41) (42) . Furthermore, secretion of immunoglobulin from normal lymphocytes is only a fraction of that from plasma cells (43) (44) (45) . Since CLL lymphocytes are unable to differentiate further from a lymphocyte to a plasma cell after induction by antigen or mitogen, it is difficult to determine whether there is really a lack of immunoglobulin secretion or whether in fact there is simply not further differentiation to the secretory plasma cell stage. Our studies indicate that CLL cells display a secretory defect of 225-MICG, a protein normally synthesized in these cells.
The mechanism of cell proliferation in CLL remains obscure. It has been proposed that malignant cells might lose an essential cell surface protein that is responsible for promoting contact inhibition of cell growth (46, 47) . In the absence of this protein, clonal expansion would go unchecked, and malignant proliferation could result. In this respect, CLL cells are known to be of monoclonal origin, and in addition display some unusual characteristics. In contrast to normal B lymphocytes, CLL cells smudge when smeared on a slide, lack the ability to form caps, and as we have shown, lack the ability to synthesize 185-MICG and to secrete 225-MICG (48, 49 
